GAL4-NF-κB Fusion Protein Augments Transgene Expression from Neuronal Promoters in the Rat Brain

Molecular Therapy

Volumn 14, Issue 6, 2006, Pages 872-882

  Liu, B H ^a,b   Yang, Y ^a,c   Paton, J F R ^b   Li, F ^a,c   Boulaire, J ^a   Kasparov, S ^b   Wang, S ^a,c  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

brain; gene transfer; neuron specific promoter; neurons; transcriptional activity

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR; SYNAPSIN I; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR GAL4; GAL4 PROTEIN, S CEREVISIAE; GREEN FLUORESCENT PROTEIN; LUCIFERASE; SACCHAROMYCES CEREVISIAE PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA;

5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACULOVIRUS; BETA CHAIN; BRAIN; BRAIN NERVE CELL; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRUS VECTOR; MALE; NONHUMAN; PHENOTYPE; PLASMID; PROMOTER REGION; PROTEIN DOMAIN; RAT; REPORTER GENE; TRANSCRIPTION INITIATION; TRANSGENE; ANIMAL; CELL STRAIN; CELL STRAIN COS1; CERCOPITHECUS; CHO CELL; CONFOCAL MICROSCOPY; CRICETULUS; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HAMSTER; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; NERVE CELL; TUMOR CELL LINE; WISTAR RAT;

MAMMALIA;

ANIMALS; BRAIN; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; CRICETULUS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; MALE; MICROSCOPY, CONFOCAL; NEURONS; PC12 CELLS; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS (GENETICS); RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSGENES;

EID: 33750996986     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2006.05.020     Document Type: Article

References (41)

1. Paterna J.C., and Bueler H. Recombinant adeno-associated virus vector design and gene expression in the mammalian brain. Methods 28 (2002) 208-218
2. Sasahara M., et al. PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell 64 (1991) 217-227
3. Kugler S., et al. Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors. Mol. Cell. Neurosci. 17 (2001) 78-96
4. Lonergan T., Teschemacher A.G., Hwang D.Y., Kim K.S., Pickering A.E., and Kasparov S. Targeting brain stem centers of cardiovascular control using adenoviral vectors: impact of promoters on transgene expression. Physiol. Genom. 20 (2005) 165-172
5. Nettelbeck D.M., Jerome V., and Muller R. Gene therapy: designer promoters for tumour targeting. Trends Genet. 16 (2000) 174-181
6. Ray S., et al. Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression. Hum. Gene Ther. 15 (2004) 681-690
7. Nettelbeck D.M., Jerome V., and Muller R. A strategy for enhancing the transcriptional activity of weak cell type-specific promoters. Gene Ther. 5 (1998) 1656-1664
8. Iyer M., Wu L., Carey M., Wang Y., Smallwood A., and Gambhir S.S. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc. Natl. Acad. Sci. USA 98 (2001) 14595-14600
9. Iyer M., et al. Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector. Mol. Ther. 10 (2004) 545-552
10. Iyer M., et al. Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy. Transgenic Res. 14 (2005) 47-55
11. Sato M., Johnson M., Zhang L., Gambhir S.S., Carey M., and Wu L. Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer. Clin. Cancer Res. 11 (2005) 3743-3749
12. Fang B., Ji L., Bouvet M., and Roth J.A. Evaluation of GAL4/TATA in vivo: induction of transgene expression by adenovirally mediated gene codelivery. J. Biol. Chem. 273 (1998) 4972-4975
13. Koch P.E., Guo Z.S., Kagawa S., Gu J., Roth J.A., and Fang B. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system. Mol. Ther. 3 (2001) 278-283
14. Segawa T., Takebayashi H., Kakehi Y., Yoshida O., Narumiya S., and Kakizuka A. Prostate-specific amplification of expanded polyglutamine expression: a novel approach for cancer gene therapy. Cancer Res. 58 (1998) 2282-2287
15. Zhang D., Sutanto E.N., and Rakoczy P.E. Concurrent enhancement of transcriptional activity and specificity of a retinal pigment epithelial cell-preferential promoter. Mol. Vision 10 (2004) 208-214
16. Kaltschmidt C., Kaltschmidt B., and Baeuerle P.A. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc. Natl. Acad. Sci. USA 92 (1995) 9618-9622
17. Bhakar A.L., et al. Constitutive nuclear factor-kappa B activity is required for central neuron survival. J. Neurosci. 22 (2002) 8466-8475
18. Mattson M.P. NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 30 (2005) 883-893
19. Meffert M.K., and Baltimore D. Physiological functions for brain NF-kappaB. Trends Neurosci. 28 (2005) 37-43
20. Fridmacher V., et al. Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection. .J. Neurosci. 23 (2003) 9403-9408
21. Liu B.H., Wang X., Ma Y.X., and Wang S. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression. Gene Ther. 11 (2004) 52-60
22. Wang S., Ma N., Gao S.J., Yu H., and Leong K.W. Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes. Mol. Ther. 3 (2001) 658-664
23. Li Y., Wang X., Guo H., and Wang S. Axonal transport of recombinant baculovirus vectors. Mol. Ther. 10 (2004) 1121-1129
24. Nolan G.P., Ghosh S., Liou H.C., Tempst P., and Baltimore D. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell 64 (1991) 961-969
25. Silver P.A., Keegan L.P., and Ptashne M. Amino terminus of the yeast GAL4 gene product is sufficient for nuclear localization. Proc. Natl. Acad. Sci. USA 81 (1984) 5951-5955
26. Thanos D., and Maniatis T. NF-kappa B: a lesson in family values. Cell 80 (1995) 529-532
27. Emami K.H., and Carey M. A synergistic increase in potency of a multimerized VP16 transcriptional activation domain. EMBO J. 11 (1992) 5005-5012
28. Kays A.R., and Schepartz A. Gal4-VP16 and Gal4-AH increase the orientational and axial specificity of TATA box recognition by TATA box binding protein. Biochemistry 41 (2002) 3147-3155
29. Wang C.Y., and Wang S. Adeno-associated virus inverted terminal repeats improve neuronal transgene expression mediated by baculoviral vectors in rat brain. Hum. Gene Ther. 16 (2005) 1219-1226
30. Duale H., Kasparov S., Paton J.F., and Teschemacher A.G. Differences in transductional tropism of adenoviral and lentiviral vectors in the rat brainstem. Exp. Physiol. 90 (2005) 71-78
31. Robinson A.J., Crawley A.C., and Hopwood J.J. Over-expression of human lysosomal alpha-mannosidase in mouse embryonic stem cells. Mol. Genet. Metab. 85 (2005) 203-212
32. Yu D., Chen D., Chiu C., Razmazma B., Chow Y.H., and Pang S. Prostate-specific targeting using PSA promoter-based lentiviral vectors. Cancer Gene Ther. 8 (2001) 628-635
33. Roemer K., Johnson P.A., and Friedmann T. Transduction of foreign regulatory sequences by a replication-defective herpes simplex virus type 1: the rat neuron-specific enolase promoter. Virus Res. 35 (1995) 81-89
34. Paulus W., Baur I., Boyce F.M., Breakefield X.O., and Reeves S.A. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 70 (1996) 62-67
35. Miller N., and Whelan J. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum. Gene Ther. 8 (1997) 803-815
36. Miyoshi H., Blomer U., Takahashi M., Gage F.H., and Verma I.M. Development of a self-inactivating lentivirus vector. J. Virol. 72 (1998) 8150-8157
37. Iwakuma T., Cui Y., and Chang L.J. Self-inactivating lentiviral vectors with U3 and U5 modifications. Virology 261 (1999) 120-132
38. Carbonell L.F., Klowden M.J., and Miller L.K. Baculovirus-mediated expression of bacterial genes in dipteran and mammalian cells. J. Virol. 56 (1985) 153-160
39. Hofmann C., Sandig V., Jennings G., Rudolph M., Schlag P., and Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. USA 92 (1995) 10099-10103
40. Stanbridge L.J., Dussupt V., and Maitland N.J. Baculoviruses as vectors for gene therapy against human prostate cancer. J. Biomed. Biotechnol. 2 (2003) 79-91
41. Coleman J.E., et al. Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo. Physiol. Genom. 12 (2003) 221-228